Franklin Resources’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Franklin Resources’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,832	Closed	-$252K	–	2752
2023 Q3	$252K	Buy	+37,832	New	+$314K	﹤0.01%	2231
2022 Q1	–	Sell	-773,700	Closed	-$4.33M	–	2558
2021 Q4	$4.33M	Sell	773,700 -226,300	-23%	-$1.7M	﹤0.01%	1259
2021 Q3	$7.69M	Buy	+1,000,000	New	+$9.12M	﹤0.01%	1109
2021 Q2	–	Sell	-1,000,000	Closed	-$10.5M	–	2089
2021 Q1	$10.5M	Hold	1,000,000	–	–	﹤0.01%	963
2020 Q4	$13.9M	Hold	1,000,000	–	–	0.01%	897
2020 Q3	$14.4M	Buy	+1,000,000	New	+$13.6M	0.01%	841

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Franklin Resources's PNT Position: Q4 2023 in Review

Franklin Resources sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 37,832 shares — an estimated $252K sold.

Franklin Resources first reported a position in PNT in Q3 2020 and held it in 6 quarters. The position peaked at $14.4M in Q3 2020. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Franklin Resources reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Franklin Resources sold 37,832 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $252K.
Franklin Resources first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Franklin Resources's POINT Biopharma Global Inc. Common Stock position peaked at $14.4M in Q3 2020.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Franklin Resources's 13F filing for Q4 2023, filed 9 Feb 2024.